(GENI) Generic Sweden publ - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001790791
GENI: Messaging, APIs, Communication, Platforms, Consulting
Generic Sweden AB (publ) is a Stockholm-based technology company specializing in advanced messaging and digital communication solutions. Since its establishment in 1993, the company has focused on delivering scalable and secure platforms for various applications, catering to both enterprise and consumer markets. Its services include messaging APIs, cloud-based communication tools, and customizable digital platforms designed to streamline interactions. The company operates with a strong emphasis on innovation and reliability, positioning itself as a key player in Swedens tech sector.
Ticker Symbol: GENI | Exchange: ST | Type: Common Stock | Country Origin: Sweden | GICS Sub Industry: IT Consulting & Other Services
From a technical standpoint, GENI is currently trading at 60.80 SEK, above its short-term (SMA 20: 57.88) and medium-term (SMA 50: 57.90) moving averages, signaling bullish momentum. The stock is also well above its long-term SMA 200 (50.87), indicating sustained upward pressure. Average trading volume over the past 20 days has been moderate at 15,624 shares, with an ATR of 1.92, reflecting relatively stable price movements.
Fundamentally, Generic Sweden AB has a market capitalization of 715.39M SEK, with a trailing P/E ratio of 25.53, suggesting investors expect significant future growth. The P/B ratio of 12.60 indicates a premium valuation relative to book value, while the P/S ratio of 4.03 reflects strong revenue multiples. The companys return on equity (RoE) stands at 56.70%, highlighting efficient profitability and strong shareholder value creation.
Additional Sources for GENI Stock
GENI Stock Overview
Market Cap in USD | 74m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception |
GENI Stock Ratings
Growth Rating | 52.4 |
Fundamental | 80.0 |
Dividend Rating | 73.5 |
Rel. Strength | 14.8 |
Analysts | - |
Fair Price Momentum | 61.98 SEK |
Fair Price DCF | 35.94 SEK |
GENI Dividends
Dividend Yield 12m | 2.72% |
Yield on Cost 5y | 7.63% |
Annual Growth 5y | 37.97% |
Payout Consistency | 98.0% |
GENI Growth Ratios
Growth Correlation 3m | 13.4% |
Growth Correlation 12m | 67.6% |
Growth Correlation 5y | 25.9% |
CAGR 5y | 25.47% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | -0.13 |
Alpha | 19.29 |
Beta | 0.634 |
Volatility | 33.67% |
Current Volume | 12.2k |
Average Volume 20d | 11.4k |
As of May 09, 2025, the stock is trading at SEK 61.40 with a total of 12,231 shares traded.
Over the past week, the price has changed by +3.19%, over one month by +9.84%, over three months by +16.73% and over the past year by +26.55%.
Yes, based on ValueRay Fundamental Analyses, Generic Sweden publ (ST:GENI) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 80.03 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GENI as of May 2025 is 61.98. This means that GENI is currently overvalued and has a potential downside of 0.94%.
Generic Sweden publ has no consensus analysts rating.
According to ValueRays Forecast Model, GENI Generic Sweden publ will be worth about 68.9 in May 2026. The stock is currently trading at 61.40. This means that the stock has a potential upside of +12.23%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.6 | -91% |
Analysts Target Price | - | - |
ValueRay Target Price | 68.9 | 12.2% |